122 related articles for article (PubMed ID: 14580011)
1. A comparison of the decontamination efficacy of foam-making blends based on cationic and nonionic tensides against organophosphorus compounds determined in vitro and in vivo.
Cabal J; Kassa J; Severa J
Hum Exp Toxicol; 2003 Sep; 22(9):507-14. PubMed ID: 14580011
[TBL] [Abstract][Full Text] [Related]
2. Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam.
Clarkson ED; Schulz SM; Railer RF; Smith KH
Toxicol Lett; 2012 Aug; 212(3):282-7. PubMed ID: 22698813
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous toxicity and decontamination of soman, VX, and paraoxon in rats using detergents.
Misík J; Pavliková R; Kuča K
Arh Hig Rada Toksikol; 2013 Jun; 64(2):25-31. PubMed ID: 23819929
[TBL] [Abstract][Full Text] [Related]
4. RSDL decontamination of human skin contaminated with the nerve agent VX.
Thors L; Lindberg S; Johansson S; Koch B; Koch M; Hägglund L; Bucht A
Toxicol Lett; 2017 Mar; 269():47-54. PubMed ID: 28179194
[TBL] [Abstract][Full Text] [Related]
5. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
[TBL] [Abstract][Full Text] [Related]
6. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 2: evaluation of in vitro topical decontamination efficacy using undamaged skin.
Dalton CH; Hall CA; Lydon HL; Chipman JK; Graham JS; Jenner J; Chilcott RP
J Appl Toxicol; 2015 May; 35(5):543-50. PubMed ID: 25219755
[TBL] [Abstract][Full Text] [Related]
7. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 2: guinea pigs challenged with soman.
Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
Cutan Ocul Toxicol; 2011 Mar; 30(1):29-37. PubMed ID: 20964500
[TBL] [Abstract][Full Text] [Related]
8. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: evaluation of in vitro clotting efficacy in the presence of certain contaminants.
Hall CA; Lydon HL; Dalton CH; Chipman JK; Graham JS; Chilcott RP
J Appl Toxicol; 2015 May; 35(5):536-42. PubMed ID: 25131713
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and reaction networks of H2O2 vapor with NH3 gas for decontamination of the toxic warfare nerve agent, VX on a solid surface.
Gon Ryu S; Wan Lee H
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2015; 50(14):1417-27. PubMed ID: 26327407
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an oximate-based skin decontaminant against organophosphate nerve agents determined in vivo and in vitro.
Sawyer TW; Parker D; Thomas N; Weiss MT; Bide RW
Toxicology; 1991 May; 67(3):267-77. PubMed ID: 2048130
[TBL] [Abstract][Full Text] [Related]
11. Decontamination of VX, GD, and HD on a surface using modified vaporized hydrogen peroxide.
Wagner GW; Sorrick DC; Procell LR; Brickhouse MD; Mcvey IF; Schwartz LI
Langmuir; 2007 Jan; 23(3):1178-86. PubMed ID: 17241030
[TBL] [Abstract][Full Text] [Related]
12. Comparison of skin decontamination efficacy of commercial decontamination products following exposure to VX on human skin.
Thors L; Koch M; Wigenstam E; Koch B; Hägglund L; Bucht A
Chem Biol Interact; 2017 Aug; 273():82-89. PubMed ID: 28601555
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous challenge with chemical warfare agents in the SKH-1 hairless mouse. (I) Development of a model for screening studies in skin decontamination and protection.
Dorandeu F; Taysse L; Boudry I; Foquin A; Hérodin F; Mathieu J; Daulon S; Cruz C; Lallement G
Hum Exp Toxicol; 2011 Jun; 30(6):470-90. PubMed ID: 20547654
[TBL] [Abstract][Full Text] [Related]
14. Comparison of selected skin decontaminant products and regimens against VX in domestic swine.
Bjarnason S; Mikler J; Hill I; Tenn C; Garrett M; Caddy N; Sawyer TW
Hum Exp Toxicol; 2008 Mar; 27(3):253-61. PubMed ID: 18650258
[TBL] [Abstract][Full Text] [Related]
15. Immediate post-dosing paralysis following severe soman and VX toxicosis in guinea pigs.
Bide RW; Schofield L; Risk DJ
J Appl Toxicol; 2005; 25(5):410-7. PubMed ID: 16092080
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis, antimicrobial effects and adverse effects of new structures of urea, hydrogen peroxide and tensides].
Jülich WD; Ohme R; Alhitari N; Adrian V; von Woedtke T; Kramer A
Pharmazie; 1999 Mar; 54(3):171-8. PubMed ID: 10192103
[TBL] [Abstract][Full Text] [Related]
17. Further studies of the efficacy of military, commercial and novel skin decontaminants against the chemical warfare agents sulphur Mustard, Soman and VX.
Matar H; Price SC; Chilcott RP
Toxicol In Vitro; 2019 Feb; 54():263-268. PubMed ID: 30347232
[TBL] [Abstract][Full Text] [Related]
18. Amazing terrorism tool: new foam could revolutionize decon.
Lindsey J
JEMS; 2003 Apr; 28(4):84, 86. PubMed ID: 12736611
[No Abstract] [Full Text] [Related]
19. Pickering emulsions for skin decontamination.
Salerno A; Bolzinger MA; Rolland P; Chevalier Y; Josse D; Briançon S
Toxicol In Vitro; 2016 Aug; 34():45-54. PubMed ID: 27021875
[TBL] [Abstract][Full Text] [Related]
20. In vitro human skin decontamination efficacy of MOF-808 in decontamination lotion following exposure to the nerve agent VX.
Larsson A; Qvarnström J; Lindberg S; Wigenstam E; Öberg L; Afshin Sander R; Johansson S; Bucht A; Thors L
Toxicol Lett; 2021 Mar; 339():32-38. PubMed ID: 33370593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
